指南与共识儿童口腔牙体牙髓病口腔颌面外科

儿童急性牙痛药物管理循证临床实践指南

Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in children: A report from the American Dental Association Science and Research Institute, the University of Pittsburgh School of Dental Medicine, and the Center for Integrative Global Oral Health at the University of Pennsylvania.
指南 / 共识 · J Am Dent Assoc · 2023-01-01

美国牙科协会科学事务委员会等机构召集指南小组,针对12岁以下儿童拔牙后急性疼痛及牙髓/根分叉/根尖周病所致牙痛的临时药物管理,开展系统评价与荟萃分析并制定循证推荐。小组共形成7条推荐和5条良好实践声明,建议使用非甾体抗炎药(如布洛芬、萘普生)单用或联合对乙酰氨基酚,而非阿片类药物;可待因和曲马多禁用于儿童急性疼痛。

要点

  • 推荐非甾体抗炎药单用或联合对乙酰氨基酚管理儿童拔牙后急性疼痛及牙痛临时处理。
  • 可待因和曲马多根据美国FDA规定禁用于儿童急性疼痛管理。
  • 尚无证据评估皮质类固醇对儿童拔牙后急性疼痛的效果。

核心结论

  • 非阿片类药物(如布洛芬、萘普生单用或联合对乙酰氨基酚)推荐用于儿童拔牙后急性疼痛及牙痛临时管理(条件性推荐,极低 certainty)。
  • 可待因和曲马多根据美国FDA规定禁用于儿童急性疼痛管理。

研究设计与样本

  • 指南小组由美国牙科协会科学事务委员会、美国牙科协会科学与研究机构、匹兹堡大学牙医学院及宾夕法尼亚大学整合全球口腔健康中心召集。
  • 基于系统评价与荟萃分析,采用GRADE方法评估证据确定性,并使用GRADE证据到决策框架形成推荐。

主要发现

  • 共形成7条推荐和5条良好实践声明,涵盖不同临床情况。
  • 与不提供镇痛治疗相比,非甾体抗炎药单用或联合对乙酰氨基酚具有小的有利净平衡。
  • 尚无证据关于皮质类固醇对儿童拔牙后急性疼痛的效果。

关键数值与推荐

  • 推荐非阿片类药物(如布洛芬、萘普生单用或联合对乙酰氨基酚)用于1颗或多颗简单及外科拔牙后急性疼痛管理及牙痛临时管理(条件性推荐,极低 certainty)。
  • 根据美国FDA,可待因和曲马多禁用于儿童急性疼痛管理。

临床怎么用

  • 临床管理中优先选择非阿片类药物如布洛芬或萘普生,可单用或联合对乙酰氨基酚。
  • 避免在儿童中使用可待因和曲马多进行急性疼痛管理。

局限性

  • 推荐基于极低 certainty 证据,尤其是关于非甾体抗炎药与对乙酰氨基酚联合使用的证据。
  • 缺乏皮质类固醇对儿童拔牙后急性疼痛效果的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A guideline panel convened by the American Dental Association Council on Scientific Affairs, American Dental Association Science and Research Institute, University of Pittsburgh School of Dental Medicine, and Center for Integrative Global Oral Health at the University of Pennsylvania conducted a systematic review and meta-analyses and formulated evidence-based recommendations for the pharmacologic management of acute dental pain after 1 or more simple and surgical tooth extractions and the temporary management of toothache (that is, when definitive dental treatment not immediately available) associated with pulp and furcation or periapical diseases in children (< 12 years). TYPES OF STUDIES REVIEWED: The authors conducted a systematic review to determine the effect of analgesics and corticosteroids in managing acute dental pain. They used the Grading of Recommendations Assessment, Development and Evaluation approach to assess the certainty of the evidence and the Grading of Recommendations Assessment, Development and Evaluation Evidence to Decision framework to formulate recommendations. RESULTS: The panel formulated 7 recommendations and 5 good practice statements across conditions. There is a small beneficial net balance favoring the use of nonsteroidal anti-inflammatory drugs alone or in combination with acetaminophen compared with not providing analgesic therapy. There is no available evidence regarding the effect of corticosteroids on acute pain after surgical tooth extractions in children. CONCLUSIONS AND PRACTICAL IMPLICATIONS: Nonopioid medications, specifically nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen alone or in combination with acetaminophen, are recommended for managing acute dental pain after 1 or more tooth extractions (that is, simple and surgical) and the temporary management of toothache in children (conditional recommendation, very low certainty). According to the US Food and Drug Administration, the use of codeine and tramadol in children for managing acute pain is contraindicated.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Carrasco-Labra A, Polk DE, Urquhart O, et al. Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in children: A report from the American Dental Association Science and Research Institute, the University of Pittsburgh School of Dental Medicine, and the Center for Integrative Global Oral Health at the University of Pennsylvania. J Am Dent Assoc. 2023. PMID: 37634915. doi:10.1016/j.adaj.2023.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。